1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish

Proteomics

Volumn 16, Issue 9, 2016, Pages 1407-1420

  Sarath Babu, Nukala ^a   Murthy, Ch Lakshmi N ^a   Kakara, Sameera ^a   Sharma, Rahul ^a   Brahmendra Swamy, Cherukuvada V ^a   Idris, Mohammed M ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Animal proteomics; Markers; MPTP; Parkinson's disease; Zebrafish

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID B RECEPTOR; ACTIN; ACTIN RELATED PROTEIN 5; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BETA SYNUCLEIN; CALCINEURIN; CHONDROITIN SULFATE SYNTHASE 1; COILED COIL HELIX COILED COIL HELIX DOMAIN CONTAINING 2 PROTEIN; COMPLEMENT COMPONENT C4B; CORTICOTROPIN RELEASING FACTOR; DESMIN A; DJ 1 PROTEIN; DNA DIRECTED DNA POLYMERASE GAMMA; DYNAMIN IIA; EUKARYOTIC TRANSLATION ELONGATION FACTOR 2B; EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA 1; GAMMA SYNUCLEIN A; GAMMA SYNUCLEIN B; HEAT SHOCK PROTEIN; KH DOMAIN CONTAINING RNA BINDING SIGANL TRANSDUCTION ASSOCIATED PROTEIN 1; LEUCINE RICH REPEAT KINASE 2; PARK11 PROTEIN; PARKIN RBR E3 UBIQUITIN PROTEIN LIGASE; PROTEIN ZO1; PTEN INDUCED PUTATIVE KINASE 1; SEPTIN 3; SERINE PROTEINASE OMI; SYNAPSIN IIB; UNCLASSIFIED DRUG; VITELLOGENIN 1; NERVE PROTEIN; PROTEOME; ZEBRAFISH PROTEIN;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BRADYKINESIA; CONTROLLED STUDY; CYTOSKELETON; DYSKINESIA; FEMALE; FREEZING; MALE; NERVE ENDING; NEUROFILAMENT; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SWIMMING; SYNAPSE VESICLE; TRANSCRIPTOMICS; ZEBRA FISH; ANIMAL; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOLECULAR GENETICS; PATHOPHYSIOLOGY; VIDEORECORDING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MOLECULAR SEQUENCE ANNOTATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE, SECONDARY; PROTEOME; VIDEO RECORDING; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84964797804     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500291     Document Type: Article

References (43)

1. Lang, A. E., Lozano, A. M., Parkinson's disease First of two parts. N. Engl. J. Med. 1998a, 339, 1044-53.
2. Lang, A. E., Lozano, A. M., Parkinson's disease Second of two parts. N. Engl. J. Med. 1998b, 339, 1130-1143.
3. Micieli, G., Tosi, P., Marcheselli, S., Cavallini, A., Autonomic dysfunction in parkinson's disease. Neurol. Sci. 2003, 24, S32-S34.
4. Zhang, Y., Dawson, V. L., Dawson, T. M., Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 2000, 7, 240-250.
5. Recchia, A., Depetto, P., Negro, A., Guidolin, D., Skaper, S. D., Giusti, P., Alpha-synuclein and Parkinson's disease. FASEB J. 2004, 18, 617-626.
6. Lesage, S., Brice, A., Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18, R48-R59.
7. Parlkinson, J., An Essay on the shaking palsy 1817. J. Neuropsychiatry Clin. Neurosci. 2002, 14, 223-236.
8. Jellinger, K. A., Basic mechanisms of neurodegeneration: a critical update. J. Cell Mol. Med. 2010, 14, 457-487.
9. Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E. et al., Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 2000, 157, 401-410.
10. Kim, E. K., Choi, E. J., Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802, 396-405.
11. Nagatsu, T., Amine-related neurotoxins in Parkinson's disease: past, present, and future. Neurotoxicol. Teratol. 2002, 24, 565-569.
12. Le Couteur, D. G., McLean, A. J., Taylor, M. C., Woodham, B. L., Board, P. G., Pesticides and Parkinson's disease. Biomed. Pharmacother. 1999, 53, 122-130.
13. Langston, J. W., Ballard, P., Tetrud, J. W., Irwin, I., Chronic Parkinsonism in humans due to a product of meperidine analogue synthesis. Science 1983, 219, 979-980.
14. Betarbet, R., Sherer, T. B., Greenamyre, J. T., Animal models of Parkinson's disease. Bioessays 2002, 24, 308-318.
15. Speciale, S. G., MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol. Teratol. 2002, 24, 607-620.
16. Pollard, H. B., Dhariwal, K., Adeyemo, O. M., Markey, C. J. et al., A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. FASEB J. 1992, 6, 3108-3116.
17. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M. et al., Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neuroscience 2000, 3, 1301-1306.
18. Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., Federoff, H. J., Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999, 823, 1-10.
19. Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, R. W., Cory-Slechta, D. A., The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 2000, 20, 9207-9214.
20. Singer, T. P., Ramsay, R. R., Mechanism of neurotoxicity of MPTP: an update. FEBS Lett. 1990, 274, 1-8.
21. Mari-Beffa, M., Mateos, I., Palmqvist, P., Becerra, J., Cell to cell interactions during teleosts fin regeneration. Int. J. Dev. Biol. 1996, 40, 179S-180S.
22. Renn, J., Winkler, C., Schartl, M., Fischer, R., Goerlich, R., Zebrafish and medaka as models for bone research including implications regarding space related issues. Protoplasma 2006, 229, 209-214.
23. Schmidt, R., Strahle, U., Scholpp, S., Neurogenesis in zebrafish - from embryo to adult. Neural dev. 2013, 8, 3.
24. Dahm, R., Geisler, R., Learning from small fry: the zebrafish as a genetic model organism for aquaculture fish species. Mar. Biotechnol. (NY) 2006, 8, 329-345.
25. Xi, Y., Noble, S., Ekker, M., Modeling neurodegeneration in zebrafish. Curr. Neurol. Neurosci. Rep. 2011, 11, 274-282.
26. Hortopan, G. A., Dinday, M. T., Baraban, S. C., Zebrafish as a model for studying aspects of epilepsy. Dis. Model Mech. 2010, 3, 144-148.
27. Chakravarty, S., Reddy, B. R., Sudhakar, S. R., Saxena, S. et al., Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction. PLoS One 2013, 8, e63302.
28. Bretaud, S., Lee, S., Guo, S., Sensitivity of zebrafish to environmental toxins in Parkinson's disease. Neurotoxicol. Teratol. 2004, 26, 857-864.
29. Wen, L., Wei, W., Gu, W., Hang, P. et al., Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314, 84-92.
30. Lu, X. L., Lin, Y. H., Wu, Q., Su, F. J. et al., Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells. BMC Complement. Altern. Med. 2015, 15, 137.
31. Lam, C. S., Korzh, V., Strahle, U., Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. 2005, 21, 1758-1762.
32. Sallinen, V., Torkko, V., Sundvik, M., Reenilä, I. et al., MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J. Neurochem. 2009, 108, 719-731.
33. Anichtchik, O. V., Kaslin, J., Peitsaro, N., Scheinin, M., Panula, P., Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J. Neurochem. 2004, 88, 443-453.
34. Brand, M., Granato, M., Nusslein-Volhard, C., "Keeping and raising zebrafish, " in: Nusslein-Volhard, C., Dahm, R. (Eds.), Zebrafish: A Practical Approach, Oxford University Press, New York 2002, pp. 7-38.
35. Cachat, J., Stewart, A., Grossman, L., Gaikwad, S. et al., Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat. Protoc. 2010, 5, 1786-1799.
36. Singh, S. K., Sundaram, C. S., Shanbhag, S., Idris, M. M., Proteomic profile of zebrafish brain based on two dimensional gel electrophoresis matrix-assisted laser desorption/ ionization MS/MS analysis. Zebrafish 2010, 7, 169-177.
37. Schaffner, W., Weissmann, C., A rapid, sensitive, and specific method for the determination of proteins in dilute solution. Anal. Biochem. 1973, 56, 502-514.
38. Singh, S. K., Lakshmi, M. G., Saxena, S., Swamy, C. V., Idris, M. M., Proteome profile of zebrafish caudal fin based on one-dimensional gel electrophoresis LCMS/MS and two-dimensional gel electrophoresis MALDI MS/MS analysis. J. Sep. Sci. 2011, 34, 225-232.
39. Purushothaman, S., Saxena, S., Meghah, V., Brahmendra Swamy, C. V. et al., Transcriptomic and proteomic analyses of Amphiura filiformis arm tissue- undergoing regeneration. J. Proteomics 2014, 112C, 113-124.
40. Bretaud, S., Allen, C., Ingham, P. W., Bandmann, O., p53-dependent neuronal cell death in a DJ-1 deficient zebriafh model of Parkinson's disease. J. Neurochem. 2007, 100, 1626-1635.
41. Singh, S. K., Rakesh, K. S., Ramamoorthy, K., Pardha Saradhi, A. V., Idris, M. M., Proteome profile of zebrafish brain based on Gel LC-ESI MS/MS analysis. J. Proteomics Bioinform. 2010, 3, 135-142.
42. Dhavan, R., Tsai, L. H., A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2, 749-759.
43. Milanese, C., Sager, J. J., Bai, Q., Farrell, T. C. et al., Hypokinesia and reduced dopamine level in zebrafish lacking β- and γ1-synucleins. J. Biol. Chem. 2012, 287, 2971-2983.